Enobia Pharma Corp — Form D
Enobia Pharma Corp of MONTREAL, A8, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-24. The offering totals $40.0M, of which $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-08-24
- Form: D
- Accession: 0001144204-11-049367
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $40.0M
- Amount sold: $20.0M
- Remaining: $20.0M
- Investors: 3
- Date of first sale: 2011-08-09
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-164842
Issuer
- Name: Enobia Pharma Corp
- CIK: 0001412621
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 2901 RACHEL ST., SUITE 23, MONTREAL, A8, H1W 4A4
- Phone: 514-596-2901
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| David L Bonita | Director | MONTREAL, A8 |
| Robert Heft | Director | MONTREAL, A8 |
| Luc L Mainville | Director | MONTREAL, A8 |
| Richard L Meadows | Director | MONTREAL, A8 |
| Frederic L Price | Director | MONTREAL, A8 |
| Thomas L Schuetz | Director | MONTREAL, A8 |
| Jonathan L Silverstein | Director | MONTREAL, A8 |
| Robert Heft | Executive Officer | MONTREAL, A8 |
| Jeffrey Mack | Executive Officer | Virginia Beach, VA |
| Eric L Trachtenberg | Executive Officer | Watertown, MA |
| David Bonita | Director | New York, NY |
| Jonathan Silverstein | Director | Chicago, IL |
| Richard Meadows | Director | Rancho Mirage, CA |
| Thomas Schuetz | Director | Cambridge, MA |
| Frederic Price | Director | Montreal, A8 |
| Luc Cournoyer | Executive Officer | Montreal, A8 |
| Luc Mainville | Director | Montreal, A8 |
Other filings by this issuer (3)
More